AWP Reform Debate Continues; U.S. Oncology Says Cut Will Hit Profits In ‘05
Executive Summary
U.S. Oncology expects that the transition from AWP-based reimbursement to ASP-based reimbursement will reduce Medicare payments to oncologists by approximately 8% in 2005
You may also be interested in...
U.S. Oncology To Go Private Ahead Of Medicare Part B Changes In 2005
U.S. Oncology plans to go private ahead of the 2005 reimbursement changes for chemotherapy drugs under the Medicare prescription drug law
U.S. Oncology To Go Private Ahead Of Medicare Part B Changes In 2005
U.S. Oncology plans to go private ahead of the 2005 reimbursement changes for chemotherapy drugs under the Medicare prescription drug law
Oncologists Seek Immediate Fixes To Medicare Part B Payment Rates
The American Society of Clinical Oncology is seeking legislation to create an "exceptions" process to ensure that Medicare Part B drug payments to oncologists cover drug acquisition costs